EcoDrugPlus

Arachidonate 15-Lipoxygenase

Ensembl ID : ENSPNYG00000017134
Gene Symbol: ALOX15
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSPNYG00000007540
Gene Symbol: ALOX5
3 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSPNYG00000014168
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSPNYG00000007863
Gene Symbol: AVPR1A
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSPNYG00000016901
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPNYG00000021402
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPNYG00000022519
Gene Symbol: AVPR2
4 Cross references
148 Possible Orthologues:

Aromatase

Ensembl ID : ENSPNYG00000011284
Gene Symbol: LOC102213235
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2-Like

Ensembl ID : ENSPNYG00000017272
Gene Symbol: LOC102192851
2 Cross references
185 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSPNYG00000007748
Gene Symbol: LOC102212857
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSPNYG00000018650
Gene Symbol: LOC102207644
2 Cross references
219 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSPNYG00000015659
Gene Symbol: LOC102207287
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).